Earnings Call Summary | Atomera(ATOM.US) Q1 2024 Earnings Conference
Earnings Call Summary | Atomera(ATOM.US) Q1 2024 Earnings Conference
The following is a summary of the Atomera Incorporated (ATOM) Q1 2024 Earnings Call Transcript:
以下是Atomera Incorporated（ATOM）2024年第一季度業績電話會議記錄的摘要：
Financial Performance:
財務業績：
Atomera reported a GAAP net loss for Q1 2024 of $4.8 million or $0.19 per share, a slight improvement from a net loss of $5 million in Q1 2023.
Q1 2024 revenues were $18,000, compared to $0 in Q1 2023 and a significant decrease from $550,000 in Q4 2023.
The company maintained a balance of cash, cash equivalents, and short-term investments of $19.3 million at the end of Q1 2024.
Atomera報告稱，2024年第一季度的GAAP淨虧損爲480萬美元，合每股虧損0.19美元，較2023年第一季度的500萬美元淨虧損略有改善。
2024年第一季度的收入爲18,000美元，而2023年第一季度爲0美元，較2023年第四季度的55萬美元大幅下降。
截至2024年第一季度末，該公司的現金、現金等價物和短期投資餘額維持在1,930萬美元。
Business Progress:
業務進展：
Development of Atomera's MST technology with STMicroelectronics is on track for production release.
The company has increased submissions for licenses and JDAs, increasing potential for new contracts and partnerships.
Atomera's partnership with the JDA2 customer shows promising early data that could lead to a licensing agreement and production.
The company is expanding its portfolio with new variations of silicon lattice films and is securing patents around structures in advanced nodes and memory area.
Atomera is actively involved with manufacturers in the RF SOI market and has made their MST CAD tools available for customers.
The company is exploring the GaN and compound semiconductor markets for new potential revenue streams.
與意法半導體共同開發的Atomera的MST技術有望量產發佈。
該公司增加了許可證和JDA的申請，增加了簽訂新合同和合作夥伴關係的可能性。
Atomera與JDA2客戶的合作顯示出令人鼓舞的早期數據，這些數據可能會導致許可協議和生產。
該公司正在通過硅晶格薄膜的新變體來擴大其產品組合，並正在獲得有關先進節點和存儲區域結構的專利。
Atomera積極參與射頻SOI市場的製造商的合作，並已向客戶提供了他們的MST CAD工具。
該公司正在探索氮化鎵和化合物半導體市場，尋找新的潛在收入來源。
More details: Atomera IR
更多詳情： Atomera 紅外
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。